Health

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

- Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's double reading system - published in The Lancet Digital Health SEOUL, South Korea, Sept. 11, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnosti...

2023-09-11 21:00 1735

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer

AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment ofSaulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience...

2023-09-11 15:00 1216

Grit Biotechnology Announces Closing of $60 Million Series B Financing

SHANGHAI, Sept. 8, 2023 /PRNewswire/ -- On September 8, 2023, Grit Biotechnology announced the completion of a Series B financing round, raising over60 million USD. The investment was led by CICC with participation from Qianhai Ark, Liando Group, Yuanhe Capital, HeFangTian Venture Partnership and...

2023-09-08 17:00 2137

Mabwell and WuXi XDC Sign Long-Term ADC Strategic Collaboration to Accelerate Global Layout of Innovative Biologics

SHANGHAI, Sept. 8, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, and WuXi XDC, a leading global CRDMO, joint announced that they have signed a LOI for long-term strategic collaboration on Mabwell's multiple ADC projects. Mabwell has...

2023-09-08 15:30 1571

World Orphan Drug Alliance Welcomes Specialised Therapeutics

* SEA's largest independent specialty pharma company Specialised Therapeutics (ST) has joined global pharma consortium committed to collaborating to provide new specialist medicines for rare diseases. * ST to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA). * Wor...

2023-09-08 04:00 1657

SOAP Health and AESOP Technology Unite to Provide Advanced AI Solutions for Clinical Decision-Support and Medical Coding

SOAP Health's conversational AI for medical encounters, risk and symptom assessment, and documentation integrates with AESOP Technology's electronic medical record data analysis for clinical decision optimization, coding, and productivity. BOCA RATON, Fla., Sept. 7, 2023 /PRNewswire/ -- SOAP Hea...

2023-09-07 21:00 1533

United Imaging Confirms Installation of Country's First uMI Panorama™ at Huntsman Cancer Institute

The award-winning 12-year old manufacturer and widely-recognized leading cancer center agreed to install United Imaging's recently unveiled innovation. HOUSTON, Texas, Sept. 7, 2023 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced t...

2023-09-07 21:00 1414

Waterdrop Inc. Announces Second Quarter 2023 Unaudited Financial Results

BEIJING, Sept. 7, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the second quarter endedJune 30, 2...

2023-09-07 18:00 4858

Isotopia Issues a call to action to the radionuclide Therapy industry.

PETAH TIKVA, Israel, Sept. 6, 2023 /PRNewswire/ -- Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes therapeutic and diagnostic radioactive isotopes. "If you are in the Lu-177 field, don't miss this information." The Lu-177 radiopharmaceutical...

2023-09-06 20:40 1598

Health In Tech Introduces New Ancillary Products to Expand Healthcare Solutions

Expands Health Care offerings with Critical Illness, Accident, Dental, Vision, Term Life, and Gap coverage options. STUART, Fla., Sept. 6, 2023 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and re-imagines self-funded health plans, is e...

2023-09-06 20:30 1533

Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 2023 International Myeloma Society Annual Meeting

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Sept. 6, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing  innovative and highly efficacious cell therapies for the treatment o...

2023-09-06 20:00 1313

Gloria Biosciences Announces Zimberelimab Approved in China for the Treatment of Recurrent or Metastatic Cervical Cancer

* The first and only anti-PD-1 antibody approved for treating cervical cancer inChina * ORR of 27.8%, mPFS of 3.7m, and mOS of 16.8m achieved as monotherapy with best-in-class potential * A Phase 3 trial (VICT-004) of zimberelimab in combination with platinum-based chemotherapy +/- bevacizu...

2023-09-06 19:00 1372

CANbridge to Participate in Two Investor Conferences in September

BEIJING and BURLINGTON, Mass., Sept. 6, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals Inc. (HKEX:1228), a global biopharmaceutical company, with a foundation inChina, committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, today a...

2023-09-06 16:06 1587

LILYSILK Honors International Day of Charity: 1,500 Eye Masks Donated to National Breast Cancer Foundation

NEW YORK, Sept. 5, 2023 /PRNewswire/ -- On the occasion of the International Day of Charity, occurring onSeptember 5, LILYSILK, the world's leading silk brand with a mission to inspire people to live better, sustainable lives, is proud to announce it is continuing its support to National Breast C...

2023-09-05 21:30 1468

Exosomes functionally deliver siRNAs in vivo to repress tumor growth

SUZHOU, China, Sept. 5, 2023 /PRNewswire/ -- VesiCURE Therapeutics Co. Ltd., a biotechnology company located in Suzhou,China, recently released a preprint on BioRxiv titled "Harnessing extracellular vesicles for efficient siRNA delivery in vitro and in vivo" (doi:https://doi.org/10.1101/2023.0...

2023-09-05 21:20 1699

Neurophet, the first company in Korea, selected by Roche Diagnostics for Startup Creasphere's APAC innovation program

- Aim to evaluate and explore the commercialization opportunities of an amyloid-positive prediction technology for Alzheimer's disease based on MRI analysis SEOUL, South Korea, Sept. 5, 2023 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced ...

2023-09-05 21:00 1785

I-Mab Announces Upcoming Participation at September Conferences

ROCKVILLE, Md. and SHANGHAI, Sept. 5, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), is a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies an...

2023-09-05 20:00 1364

David Topper Joined Inmagene as CFO

SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, today announced the appointment ofDavid Topper as Chief Financial Officer (C...

2023-09-05 20:00 1542

Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile

Alteogen expects Tergase® will replace commercially available animal-derived hyaluronidase products and their significant disadvantages.  Compared with other commercially available hyaluronidase products, Tergase® showed no incidence of anti-drug antibodies (ADA).  The occurrence of ADA is known ...

2023-09-05 20:00 1250

Baird Medical's Single-Use Sterile Biopsy Needle Receives Approval from Jiangsu Medical Products Administration in China

GUANGZHOU, China, Sept. 5, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, today announced that its subsidiary, Nanjing Changcheng Medical Equipment Co., Ltd., h...

2023-09-05 17:00 1246
1 ... 64656667686970 ... 273